Research map: Melanocortin-4 receptor regulation of endocrine axes and clinical effects of setmelanotide

Back to the article

Papers in this map

  1. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing · Yoav Benjamini · 1995 · 112507 citations · Cited by this paper
  2. Application of Theranostics in Thyroid Cancer Management · 2026 · Related
  3. Role of leptin in the neuroendocrine response to fasting · Rexford S. Ahima · 1996 · 3173 citations · Cited by this paper
  4. Medical treatments for obesity: what does the future have in store? · 2026 · Related
  5. Mechanisms, Pathophysiology, and Management of Obesity · Steven B. Heymsfield · 2017 · 1897 citations · Cited by this paper
  6. Inter-individual variation in gastric emptying is related to GLP-1 response to intraduodenal glucose exposure in health · 2026 · Related
  7. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey · Philip L. Beales · 1999 · 982 citations · Cited by this paper
  8. Low serum testosterone concentrations predict incident frailty in men with HIV · 2026 · Related
  9. Bardet–Biedl syndrome · Elizabeth L. Forsythe · 2012 · 764 citations · Cited by this paper
  10. Treatment of severe hypertriglyceridemia: a new era dawns · 2026 · Related
  11. Obesity and the pubertal transition in girls and boys · Christine M Burt Solorzano · 2010 · 461 citations · Cited by this paper
  12. Impairment in the hypothalamic–pituitary–gonadal axis in males with medullary thyroid carcinoma treated with selpercatinib · 2026 · Related
  13. Sperm DNA damage caused by oxidative stress: modifiable clinical, lifestyle and nutritional factors in male infertility · C Wright · 2014 · 398 citations · Cited by this paper
  14. Is the diagnosis of Cushing disease moving beyond bilateral inferior petrosal sinus sampling? · 2026 · Related
  15. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period · Andrea Maria Haqq · 2022 · 202 citations · Cited by this paper
  16. Prospective evaluation of the effect of stopping estrogen-containing contraceptives on serum CBG and cortisol levels · 2026 · Related
  17. Leptin signaling and circuits in puberty and fertility · Carol Fuzeti Elias · 2012 · 188 citations · Cited by this paper
  18. Consensus on Biomarker Utility for ACTH-Dependent Cushing’s Syndrome: A Pituitary Society Modified Delphi Panel · 2026 · Related
  19. Obesity is associated with increased serum TSH level, independent of thyroid function · Mehmet Baştemir · 2007 · 139 citations · Cited by this paper
  20. Kisspeptin and energy balance in reproduction · Julie‐Ann P. De Bond · 2013 · 125 citations · Cited by this paper
  21. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R) · Daniel L. Marks · 2005 · 116 citations · Cited by this paper
  22. NPY and MC4R Signaling Regulate Thyroid Hormone Levels during Fasting through Both Central and Peripheral Pathways · Kristen R. Vella · 2011 · 104 citations · Cited by this paper
  23. The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population · Safa Mujahid · 2018 · 102 citations · Cited by this paper
  24. Caloric restriction: Impact upon pituitary function and reproduction · Bronwen Martin · 2008 · 90 citations · Cited by this paper
  25. Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations · Hélène Dollfus · 2024 · 77 citations · Cited by this paper
  26. A review of the literature of Bardet–Biedl disease and report of three cases associated with metabolic syndrome and diagnosed after the age of fifty · S. Iannello · 2002 · 68 citations · Cited by this paper
  27. Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats. · Donald L. St. Germain · 1985 · 64 citations · Cited by this paper
  28. Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis · Renuka Suvarna · 2024 · 61 citations · Cited by this paper
  29. Role of melanocortin signaling in the regulation of the hypothalamic–pituitary–thyroid (HPT) axis · Ronald Michael Lechan · 2005 · 60 citations · Cited by this paper
  30. Reduction in corpora lutea number in obese melanocortin-4-receptor-deficient mice · Mara Sandrock · 2009 · 60 citations · Cited by this paper
  31. Diet-Induced Growth Is Regulated via Acquired Leptin Resistance and Engages a Pomc-Somatostatin-Growth Hormone Circuit · Heiko Löhr · 2018 · 56 citations · Cited by this paper
  32. Effects of Melanocortin 3 and 4 Receptor Deficiency on Energy Homeostasis in Rats · Panpan You · 2016 · 52 citations · Cited by this paper
  33. Reversible male hypogonadotropic hypogonadism due to energy deficit · Henry K. Wong · 2019 · 43 citations · Cited by this paper
  34. The Molecular Basis of Male Infertility in Obesity: A Literature Review · Biji Thomas George · 2023 · 42 citations · Cited by this paper
  35. Deficient melanocortin-4 receptor causes abnormal reproductive neuroendocrine profile in female mice · Xiaolin Chen · 2016 · 27 citations · Cited by this paper
  36. Regulation of Thyroid Hormone Levels by Hypothalamic Thyrotropin-Releasing Hormone Neurons · Ricardo Henrique Costa-e-Sousa · 2023 · 27 citations · Cited by this paper
  37. Neuroendocrine adaptations to starvation · Tânia Amorim · 2023 · 26 citations · Cited by this paper
  38. Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone · H. Y. Tan · 2016 · 25 citations · Cited by this paper
  39. Leptin Modulates the Response of Brown Adipose Tissue to Negative Energy Balance: Implication of the GH/IGF-I Axis · Vicente Barrios · 2021 · 22 citations · Cited by this paper

Source: OpenAlex (CC0)